文献速递心律失常瓣膜病与结构性心脏病

先天性心脏病患者导管消融:法国全国性研究

Catheter ablation in congenital heart diseases: a French nationwide study.
PubMed 文献 · Eur Heart J · 2026-01-01

这项前瞻性研究纳入2020年至2024年7月法国28个中心的998例先天性心脏病患者,共1135次导管消融术。主要临床心律失常为心房扑动/心动过速(59.6%)、心房颤动(17.2%)、室性心律失常(16.6%)和房室折返性心动过速(3.3%)。临床心律失常消融急性成功率为94.4%,急性并发症发生率3.8%,1年和2年无复发率分别为77.3%和68.4%。

要点

  • 先天性心脏病患者导管消融急性成功率高(94.4%),并发症率低(3.8%)。
  • 室性心律失常急性成功率86.7%,低于其他心律失常类型。
  • 1年和2年无复发率分别为77.3%和68.4%,复发率因心律失常类型和基础先心病而异。

核心结论

  • 先天性心脏病患者导管消融急性结局良好且并发症率低,但复发率因靶心律失常和基础先心病类型而异,需在获益-风险评估中考虑。

研究设计与样本

  • 前瞻性研究,纳入2020年至2024年7月法国28个中心的所有转诊接受导管消融的先天性心脏病患者,共998例患者、1135次手术。

主要发现

  • 主要靶心律失常为心房扑动/心动过速677例(59.6%)、心房颤动195例(17.2%)、室性心律失常188例(16.6%)、房室折返性心动过速38例(3.3%)。
  • 临床心律失常消融急性成功1071例(94.4%),每次手术平均靶心律失常数1.5±0.7,除室性心律失常(86.7%)外所有心律失常急性成功率超过90%。
  • 急性并发症发生于43次手术(3.8%),包括1例(0.1%)死亡。
  • 总体1年和2年无复发率分别为77.3%(95%CI 74.2%-80.4%)和68.4%(95%CI 64.7%-72.3%)。

临床怎么用

  • 对于先天性心脏病合并心律失常患者,导管消融可作为急性成功率较高的治疗选择,但需根据心律失常类型和基础先心病评估复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Current evidence on catheter ablation for patients with congenital heart disease (CHD) is derived from small, retrospective studies. This study aims to provide insights from a nationwide contemporary registry. METHODS: This prospective study included all CHD patients referred for catheter ablation from 2020 to July 2024 across 28 French centres. The primary outcome was the rate of per-procedural acute success. Secondary outcomes included complications as well as freedom from arrhythmia recurrence. RESULTS: A total of 1135 consecutive catheter ablation procedures were performed in 998 patients (mean age 46.1 ± 16 years, 55.5% male). The main primary clinical arrhythmias targeted were atrial flutter/tachycardia in 677 (59.6%), atrial fibrillation in 195 (17.2%), ventricular arrhythmia in 188 (16.6%), and atrioventricular reentrant tachycardia in 38 (3.3%), with significant variations in patterns observed based on the underlying substrate. Clinical arrhythmia was successfully ablated in 1071 patients (94.4%). The mean number of arrhythmias targeted per procedure was 1.5 ± 0.7, with overall acute success rates exceeding 90% for all arrhythmias except for ventricular arrhythmias (86.7%). Acute complication occurred in 43 procedures (3.8%), including 1 (0.1%) death. The overall 1- and 2-year recurrence-free rates were 77.3% (95% confidence interval 74.2%-80.4%) and 68.4% (95% confidence interval 64.7%-72.3%), respectively. Significant variations in recurrence rates were noted based on the type of arrhythmia and the underlying CHD. CONCLUSIONS: Catheter ablation in patients with CHD demonstrates highly favourable acute outcomes and a low complication rate. Recurrence rates during follow-up vary depending on the targeted arrhythmia and the underlying CHD. These findings should be considered in the benefit-risk assessment.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Waldmann V, Duthoit G, Pasquié JL, et al. Catheter ablation in congenital heart diseases: a French nationwide study. Eur Heart J. 2026. PMID: 40396276. doi:10.1093/eurheartj/ehaf343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。